Novo Nordisk has officially launched its widely used type 2 diabetes drug Ozempic in India.
This marks a significant milestone for diabetes care, especially as india faces a rapidly rising number of patients with type 2 diabetes and obesity.
Ozempic was approved by the CDSCO in october for use in adult type 2 diabetes patients.
The drug is available as a once-weekly pre-filled injection pen, designed for convenience and consistent use.
How Ozempic Works
Ozempic contains semaglutide, which has multiple therapeutic effects:
Helps regulate blood sugar levels
Reduces appetite
Supports long-term weight management
Helps maintain better glycemic stability
Experts emphasize that the drug is not a quick-fix weight loss remedy.
According to Dr. Unnikrishnan (Chelaram diabetes Institute), Ozempic is most effective when combined with:
Regular physical activity
Balanced diet
Consistent medication routines
Additional health benefits may include a lowered risk of heart disease and kidney complications in diabetes patients.
Why india Is a Key Market
India has the second-highest number of type 2 diabetes patients globally.
Obesity cases are rising quickly, increasing demand for medications related to:
Weight management
Blood sugar control
The global market for such drugs is projected to reach $150 billion in the coming years.
Ozempic, approved in the US since 2017, gained massive popularity due to its weight loss potential.
In india, it can be prescribed only by endocrinologists or internal medicine specialists, and not for cosmetic or general weight loss use.
Ozempic Prices in India
0.25 mg – ₹8,800
0.5 mg – ₹10,170
1 mg – ₹11,175
Company Claims
Vikrant Shrotriya, Head of Novo Nordisk india, states that Ozempic may help diabetic patients lose up to 8 kg.
The drug may also support heart and kidney health, in addition to controlling blood sugar.
Disclaimer:
The information contained in this article is for general informational purposes only. While we strive to ensure accuracy, we make no warranties or representations of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the content. Any reliance you place on the information is strictly at your own risk. The views, opinions, or claims expressed in this article are those of the author and do not necessarily reflect the official policy or position of any organization mentioned. We disclaim any liability for any loss or damage arising directly or indirectly from the use of this article.
click and follow Indiaherald WhatsApp channel